BOSTON, May 28, 2025 -- Aktis Oncology, Inc., an oncology company focused on unlocking the breakthrough potential of targeted radiopharmaceuticals for patient populations not addressed by existing platform technologies, today announced...
Plexigen
Plexigen developed a proprietary 3-D biochip designed to significantly enhance the capacity, efficiency, accuracy and automation of gene screening.
Plexigen
Cary, NC
